TABLE 4.
Study | Location | Size | Nonmalignant Respiratory Disease (NMRD) |
---|---|---|---|
Fordyce et al34 | Vermont (United States) | 427 | Significant elevations in NMRD (SMR, 2.73; 95% CI, 2.10–3.48) and other NMRDs (SMR, 4.13; 95% CI, 2.88–5.74) |
Wild et al33 | France (FR) and Austria (AU) | 1070 (FR) + 542 (AU) | Nonsignificant excess mortality for NMRD in the French cohort due to pneumoconiosis (SMR, 5.56; three observed; 95% CI, 1.12–16.2) Increased mortality in the highest exposure groups (odds ratio [OR] of 2.5 for a cumulative exposure > 800 y.mg/m3) with a significant trend (OR of 1.08 per 100 y.mg/m3) with cumulative exposure to talc |
Wergeland et al35 | Norway | 390 | No excess mortality from NMRD, but a large healthy worker effect present |
Ciocan et al31 | Italy | 1749 | Increased mortality from pneumoconiosis (SMR, 9.55; 95% CI, 7.43–12.08); the mortality increased with longer (25+) years of employment with an SMR of 15.12 (95% CI, 10.89–20.43). |
CI, confidence interval; SMR, standardized mortality ratio.